Upgrade to Finviz Elite: Get our fastest platform speed, real-time data, and unlimited screening & charting. Start Free Trial

Last Close
May 26  •  04:00PM ET
6.98
Dollar change
-0.07
Percentage change
-0.99
%
Index
-
P/E
-
EPS (ttm)
-19.68
Insider Own
85.08%
Shs Outstand
2.78M
Perf Week
6.08%
Market Cap
19.64M
Forward P/E
-
EPS next Y
-1.75
Insider Trans
0.00%
Shs Float
0.39M
Perf Month
-5.42%
Enterprise Value
17.02M
PEG
-
EPS next Q
-1.39
Inst Own
0.92%
Perf Quarter
39.32%
Income
-25.87M
P/S
0.94
EPS this Y
66.54%
Inst Trans
-2.74%
Perf Half Y
11.86%
Sales
20.92M
P/B
3.08
EPS next Y
60.43%
ROA
-83.16%
Perf YTD
0.88%
Book/sh
2.26
P/C
1.72
EPS next 5Y
57.23%
ROE
-209.10%
52W High
15.36 -54.56%
Perf Year
-53.84%
Cash/sh
4.06
P/FCF
-
EPS past 3/5Y
13.32% 24.32%
ROIC
-176.25%
52W Low
4.14 68.60%
Perf 3Y
-86.06%
Dividend Est.
-
EV/EBITDA
-
Sales past 3/5Y
58.72% 38.06%
Gross Margin
24.59%
Volatility
8.74% 7.82%
Perf 5Y
-95.53%
Dividend TTM
-
EV/Sales
0.81
EPS Y/Y TTM
46.19%
Oper. Margin
-83.53%
ATR (14)
0.55
Perf 10Y
-99.96%
Dividend Ex-Date
-
Quick Ratio
1.82
Sales Y/Y TTM
-17.67%
Profit Margin
-123.66%
RSI (14)
54.41
Dividend Gr. 3/5Y
- -
Current Ratio
2.40
EPS Q/Q
-21.11%
SMA20
2.91%
Beta
0.33
Payout
-
Debt/Eq
1.40
Sales Q/Q
-22.07%
SMA50
2.34%
Rel Volume
0.90
Prev Close
7.05
Employees
81
LT Debt/Eq
1.33
SMA200
-4.30%
Avg Volume
14.39K
Price
6.98
IPO
Sep 12, 2014
Option/Short
No / Yes
Trades
Volume
12,994
Change
-0.99%
Date Action Analyst Rating Change Price Target Change
Feb-10-25Initiated Laidlaw Buy $10
Apr-03-17Downgrade Barclays Equal Weight → Underweight $2.50 → $1.50
Dec-16-16Initiated Oppenheimer Outperform
Jul-15-16Initiated Piper Jaffray Overweight $10
May-22-15Upgrade Canaccord Genuity Hold → Buy $11 → $17
May-08-15Reiterated Barclays Equal Weight $20 → $13
Oct-07-14Initiated Barclays Equal Weight $28
May-19-26 08:00AM
May-15-26 07:01PM
12:42PM
09:02AM
08:00AM
09:25AM Loading…
May-11-26 09:25AM
May-04-26 08:00AM
Mar-25-26 04:10PM
Mar-18-26 03:02PM
08:17AM
08:00AM
Mar-17-26 09:24AM
Mar-13-26 08:00AM
Mar-11-26 08:00AM
Mar-10-26 04:15PM
08:00AM Loading…
Mar-02-26 08:00AM
Feb-25-26 08:00AM
Feb-20-26 08:00AM
Feb-17-26 08:00AM
Jan-13-26 08:00AM
Dec-19-25 04:05PM
Dec-17-25 08:00AM
Dec-03-25 08:00AM
Nov-17-25 08:00AM
Nov-14-25 04:01PM
08:11AM
08:00AM
Nov-13-25 07:31AM
Nov-10-25 07:00AM
Sep-09-25 08:45AM
08:30AM Loading…
08:30AM
Sep-08-25 08:30AM
Aug-14-25 09:10AM
08:06AM
08:00AM
Aug-13-25 08:00AM
Aug-12-25 06:00PM
Aug-07-25 05:30PM
05:25PM
Aug-06-25 10:50AM
Aug-05-25 06:20PM
Aug-04-25 08:30AM
Jul-07-25 11:00AM
Jun-26-25 04:15PM
09:15AM
Jun-25-25 09:10AM
Jun-24-25 04:05PM
May-20-25 08:00AM
May-19-25 08:30AM
06:00AM
May-16-25 03:08AM
May-15-25 09:15AM
08:00AM
May-08-25 08:30AM
May-07-25 04:30PM
Apr-29-25 08:30AM
Apr-24-25 08:30AM
Apr-16-25 07:13AM
Apr-15-25 08:15AM
Mar-23-25 08:40AM
Mar-13-25 09:15AM
Mar-08-25 02:03AM
Mar-07-25 08:00AM
Mar-06-25 08:00AM
Mar-05-25 08:00AM
Feb-28-25 08:00AM
Feb-19-25 09:10AM
Feb-06-25 08:20AM
Feb-05-25 08:00AM
Feb-04-25 08:00AM
Jan-13-25 08:30AM
07:45AM
Jan-08-25 04:15PM
Jan-07-25 08:05AM
Dec-27-24 05:49PM
Nov-19-24 08:30AM
Nov-13-24 02:08AM
Nov-12-24 08:00AM
Nov-07-24 04:05PM
Nov-05-24 04:38PM
Nov-04-24 08:00AM
Oct-24-24 04:30PM
Sep-24-24 05:00PM
Sep-12-24 08:30AM
Sep-10-24 08:30AM
Sep-05-24 08:30AM
Sep-04-24 04:15PM
Aug-15-24 08:00AM
Aug-08-24 04:15PM
Jul-02-24 04:30PM
Jun-26-24 08:30AM
Jun-11-24 10:50AM
Jun-04-24 04:30PM
May-28-24 03:32AM
May-16-24 08:18AM
May-15-24 09:10AM
08:00AM
May-14-24 12:00PM
May-07-24 04:30PM
May-02-24 10:01AM
Lifeward Ltd. is a medical device company, which engages in the design, development and marketing of wearable robotic exoskeletons. The firm's exoskeletons provide hip and knee motion to enable individuals with spinal cord injury (SCI) to stand upright, walk, turn, and climb and descend stairs. Its products include ReWalk Exo-Suit and ReWalk Personal 6.0. The company was founded by Amit Goffer on June 20, 2001 and is headquartered in Hudson, MA.
PresidentMr. William Mark Grant
Chief Financial OfficerMr. Almog Adar
Vice President of Market Access & StrategyMs. Jeannine Lynch
Vice President of OperationsMs. Miri Pariente
Vice President of Customer ServiceMs. Judy Kula
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
Lynch JeannineVP of Market Access & StrategySep 02 '25Sale0.641,5911,01846,067Sep 04 05:07 PM